Effective inhibition of metastasis in triple-negative breast cancer (TNBC) mouse model by combining immunogenic chemotherapy and immune checkpoint blockade

被引：0
|
作者：
Yuan, Xiangliang [1 ]
Xiao, Yi [1 ]
Liu, Xianghua [1 ]
Kuo, Wenling [1 ]
Li, Hongzhong [1 ]
Li, Ping [1 ]
Yagita, Hideo [2 ]
Yu, Dihua [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Juntendo Univ, Sch Med, Tokyo, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4565
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4565
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combining Chemotherapy and Immunotherapy for the Treatment of Triple-Negative Breast Cancer
    McArthur, Heather
    ONCOLOGY-NEW YORK, 2019, 33 (04): : 137 - 140
  • [22] Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go From Here
    Kwa, Maryann J.
    Adams, Sylvia
    CANCER, 2018, 124 (10) : 2086 - 2103
  • [23] The role of immune checkpoint inhibition in triple negative breast cancer
    Tarekegn, Kidist
    Keskinkilic, Merve
    Kristoff, Tyler J.
    Evans, Sean T.
    Kalinsky, Kevin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (10) : 1095 - 1106
  • [24] Predictors of response to neoadjuvant checkpoint inhibition with chemotherapy in triple-negative breast cancer (TNBC): A meta-analysis of randomized control trials (RCTs)
    Roy, A. M.
    Attwood, K.
    Gandhi, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S192 - S192
  • [25] ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer
    Punie, K.
    Matikas, A.
    ESMO OPEN, 2021, 6 (01)
  • [26] Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer
    Sceneay, Jaclyn
    Goreczny, Gregory J.
    Wilson, Kristin
    Morrow, Sara
    DeCristo, Molly J.
    Ubellacker, Jessalyn M.
    Qin, Yuanbo
    Laszewski, Tyler
    Stover, Daniel G.
    Barrera, Victor
    Hutchinson, John N.
    Freedman, Rachel A.
    Mittendorf, Elizabeth A.
    McAllister, Sandra S.
    CANCER DISCOVERY, 2019, 9 (09) : 1208 - 1227
  • [27] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [28] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [29] Phosphoproteomic portraits of triple-negative breast cancer (TNBC)
    Quintela-Fandino, Miguel
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez, Gonzalo
    Pisano, David G.
    Munoz, Javier
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC)
    Basho, R.
    Janku, F.
    Helgason, T.
    Gilcrease, M.
    Booser, D.
    Karp, D.
    Meric-Bernstam, F.
    Wheler, J.
    Valero, V.
    Albarracin, C.
    Litton, J.
    Chavez-MacGregor, M.
    Ibrahim, N.
    Murray, J.
    Koenig, K.
    Hong, D.
    Subbiah, V.
    Kurzrock, R.
    Moulder, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S89 - S290
12345